Treace Medical Concepts, Inc. TMCI
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -4.24% | -10.22% | -9.01% | 11.37% | 6.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.24% | -10.22% | -9.01% | 11.37% | 6.60% |
| Cost of Revenue | 1.39% | -8.30% | -8.41% | 17.36% | 9.73% |
| Gross Profit | -5.68% | -10.71% | -9.15% | 9.89% | 5.82% |
| SG&A Expenses | -6.17% | -3.78% | 2.60% | 7.34% | -5.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.26% | -5.56% | -0.68% | 7.75% | -2.24% |
| Operating Income | 11.88% | -10.17% | -2,802.94% | 3.03% | 20.62% |
| Income Before Tax | 8.77% | -12.81% | -1,775.05% | -6.04% | 17.96% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.77% | -12.81% | -1,775.05% | -6.04% | 17.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.77% | -12.81% | -1,775.05% | -6.04% | 17.96% |
| EBIT | 11.88% | -10.17% | -2,802.94% | 3.03% | 20.62% |
| EBITDA | 9.22% | -23.98% | -498.26% | 8.31% | 25.27% |
| EPS Basic | 11.63% | -9.45% | -1,738.75% | -3.89% | 19.17% |
| Normalized Basic EPS | 11.65% | -9.45% | -1,204.00% | 2.53% | 19.16% |
| EPS Diluted | 11.63% | -9.45% | -1,287.74% | -3.89% | 19.17% |
| Normalized Diluted EPS | 11.65% | -9.45% | -1,204.00% | 2.53% | 19.16% |
| Average Basic Shares Outstanding | 3.24% | 3.08% | 2.44% | 2.07% | 1.49% |
| Average Diluted Shares Outstanding | 3.24% | 3.08% | 2.44% | 2.07% | 1.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |